Member Contact: Pierre Nathie
Industry: Industry Support Services
“De-risking the commercialisation of Health-Tech innovations”
Med2Mark provides global strategic and tactical commercialisation consulting for the HealthTech industry, research organisations and government agencies. Med2Mark thoroughly assesses the commercial value of HealthTech innovations before significant investments are committed.
Its Principal, Pierre Nathie, is an internationally experienced business leader with a successful track record bringing healthcare innovations to the American and European markets. The strength of his approach resides in the combination of quantification models with detailed questioning around real life implementation.
Med2Mark also leverages the skills and experience of Regulatory and Medical experts in the US and Europe.
Assessment of HealthTech innovations’ medical value in Health Economics terms and identification of reimbursements options in key markets.
Quantification of market values, financial returns and exit options.
Mapping of the commercialisation path at early development stage, identification of global partners.